Literature DB >> 26476224

Etiology and Pathogenesis of Psoriatic Arthritis.

Jennifer L Barnas1, Christopher T Ritchlin2.   

Abstract

The current model of psoriatic arthritis implicates both the IL-23/IL-17 axis and the tumor necrosis factor (TNF) pathways in disease pathogenesis. Although specific major histocompatibility complex class I molecules are associated with the psoriatic disease phenotype, no specific antigen or autoantibody has been identified. Instead, an array of genes may code for an autoinflammatory loop, potentially activated by mechanical stress and dysbiosis in the skin or gut. Danger signals released by innate immune cells activate a Th1 and Th17 response that leads to synovitis, enthesitis, axial inflammation, and altered bone homeostasis characterized by pathologic bone resorption and new bone formation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dactylitis; Enthesitis; IL-17; IL-23; Inflammatory arthritis; Psoriasis; Psoriatic arthritis; Spondyloarthropathy

Mesh:

Year:  2015        PMID: 26476224     DOI: 10.1016/j.rdc.2015.07.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  25 in total

1.  Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels.

Authors:  Manca Ogrič; Polona Žigon; David Drobne; Borut Štabuc; Snezna Sodin-Semrl; Saša Čučnik; Sonja Praprotnik
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 2.  The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.

Authors:  Judith A Smith
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

3.  Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis.

Authors:  M De Andrea; M De Santis; V Caneparo; E Generali; S Sirotti; N Isailovic; G M Guidelli; A Ceribelli; M Fabbroni; A Simpatico; L Cantarini; P Gisondi; L Idolazzi; M Gariglio; C Selmi
Journal:  Clin Exp Immunol       Date:  2019-10-15       Impact factor: 4.330

4.  NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.

Authors:  Zhenke Wen; Yasuhiro Shimojima; Tsuyoshi Shirai; Yinyin Li; Jihang Ju; Zhen Yang; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 5.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

6.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

7.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

Review 8.  Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis.

Authors:  Ennio Lubrano; Fabio Massimo Perrotta
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

Review 9.  New therapies for psoriasis and psoriatic arthritis.

Authors:  Christopher T Ritchlin; James G Krueger
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

Review 10.  Bedside to bench: defining the immunopathogenesis of psoriatic arthritis.

Authors:  Arlene Bravo; Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2019-09-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.